A survey of clinicians regarding preferred severity assessment tools for hidradenitis suppurativa
Int J Dermatol
.
2021 Jun;60(6):e248-e251.
doi: 10.1111/ijd.15295.
Epub 2020 Nov 12.
Authors
Rob L Shaver
1
,
Gregor B E Jemec
2
3
,
Rebecca Freese
4
,
Afsaneh Alavi
5
6
,
Michelle A Lowes
7
,
Noah Goldfarb
8
9
Affiliations
1
School of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
2
Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
3
Department of Dermatology, University of Copenhagen, Copenhagen, Denmark.
4
Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA.
5
Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
6
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
7
The Rockefeller University, New York, NY, USA.
8
Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN, USA.
9
Departments of Medicine and Dermatology, Minneapolis Veteran Affairs Health Care System, Minneapolis, MN, USA.
PMID:
33179770
PMCID:
PMC8106619
DOI:
10.1111/ijd.15295
No abstract available
Publication types
Letter
MeSH terms
Hidradenitis Suppurativa* / diagnosis
Humans
Severity of Illness Index
Surveys and Questionnaires
Grants and funding
UL1 TR002494/TR/NCATS NIH HHS/United States